Michelle LaSpaluto | Vice President-Strategic Planning and Investor Relations |
Mike Sherman | President and Chief Executive Officer |
Allen Melemed | Chief Medical Officer |
Mike Andriole | Chief Financial and Business Officer |
Randall Lanier | Chief Science Officer |
Josh Allen | Chief Technology Officer-Imipridones |
Maury Raycroft | Jefferies |
Joseph Thome | Cowen |
Ed White | H.C. Wainwright |
Soumit Roy | Jones Research |
Good afternoon, ladies and gentlemen, and welcome to the Chimerix Second Quarter 2022 Earnings Conference Call. I would now like to introduce you to your host for today's call, Michelle LaSpaluto, Vice President of Strategic Planning and Investor Relations at Chimerix. Please proceed.
Thank you and good morning everyone. This afternoon we issue a press release on our second quarter operating update.